A carregar...
Tumor progression-related transmembrane protein aspartate β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma
BACKGROUND/AIMS: Hepatocellular carcinoma (HCC) has a poor survival rate due to recurrent intrahepatic metastases and lack of effective adjuvant therapy. Aspartate-β-hydroxylase (ASPH) is an attractive cellular target since it is a highly conserved transmembrane protein overexpressed on both murine...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3328647/ https://ncbi.nlm.nih.gov/pubmed/22245894 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhep.2011.12.016 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|